The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative.


Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 15 04 2019
revised: 12 05 2019
accepted: 13 05 2019
pubmed: 7 6 2019
medline: 20 8 2019
entrez: 8 6 2019
Statut: ppublish

Résumé

Soft-tissue sarcomas (STSs) are often treated with resection and radiation (RT)±chemotherapy. The role of RT in decreasing resection width to achieve local control is unclear. We evaluated RT on margin width to achieve local control and local recurrence (LR). From 2000 to 2016, 514 patients with localized STS were identified from the US Sarcoma Collaborative database. Patients were stratified by a margin and local control was compared amongst treatment groups. LR was 9% with positive, 4.2% with ≤1 mm, and 9.3% with >1 mm margins (P = .315). In the ≤1 mm group, LR was 5.7% without RT, 0% with preoperative RT, and 0% with postoperative RT (P < .0001). In the >1 mm group, LR was 10.2%, 0%, and 3.7% in the no preoperative and postoperative RT groups, respectively (P = .005). RT did not influence LR in patients with positive margins. In stage I-III and II-III patients, local recurrence-free survival was higher following RT (P = .008 and P = .05, respectively). RT may play a larger role in minimizing LR than margin status. In patients with positive margins, RT may decrease LR to similar rates as a negative margin without RT and may be considered to decrease the risk of LR with anticipated close/positive margins.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Soft-tissue sarcomas (STSs) are often treated with resection and radiation (RT)±chemotherapy. The role of RT in decreasing resection width to achieve local control is unclear. We evaluated RT on margin width to achieve local control and local recurrence (LR).
METHODS METHODS
From 2000 to 2016, 514 patients with localized STS were identified from the US Sarcoma Collaborative database. Patients were stratified by a margin and local control was compared amongst treatment groups.
RESULTS RESULTS
LR was 9% with positive, 4.2% with ≤1 mm, and 9.3% with >1 mm margins (P = .315). In the ≤1 mm group, LR was 5.7% without RT, 0% with preoperative RT, and 0% with postoperative RT (P < .0001). In the >1 mm group, LR was 10.2%, 0%, and 3.7% in the no preoperative and postoperative RT groups, respectively (P = .005). RT did not influence LR in patients with positive margins. In stage I-III and II-III patients, local recurrence-free survival was higher following RT (P = .008 and P = .05, respectively).
CONCLUSIONS CONCLUSIONS
RT may play a larger role in minimizing LR than margin status. In patients with positive margins, RT may decrease LR to similar rates as a negative margin without RT and may be considered to decrease the risk of LR with anticipated close/positive margins.

Identifiants

pubmed: 31172531
doi: 10.1002/jso.25522
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-331

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Nicholas P Gannon (NP)

Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin.

David M King (DM)

Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin.

Cecilia G Ethun (CG)

Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia.

John Charlson (J)

Division of Hematology and Oncology, Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

Thuy B Tran (TB)

Department of Surgery, Stanford University, Palo Alto, California.

George Poultsides (G)

Department of Surgery, Stanford University, Palo Alto, California.

Valerie Grignol (V)

Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, Ohio.

J Harrison Howard (JH)

Division of Surgical Oncology, Department of Surgery, University of South Alabama, Mobile, Alabama.

Jennifer Tseng (J)

Department of Surgery, University of Chicago, Chicago, Illinois.

Kevin K Roggin (KK)

Department of Surgery, University of Chicago, Chicago, Illinois.

Konstantinos Votanopoulos (K)

Department of Surgery, Wake Forest University, Winston-Salem, North Carolina.

Bradley Krasnick (B)

Department of Surgery, Washington University, St. Louis, Missouri.

Ryan C Fields (RC)

Department of Surgery, Washington University, St. Louis, Missouri.

Kenneth Cardona (K)

Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia.

Meena Bedi (M)

Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH